Trademark: 79135148
Status Date
Saturday, April 1, 2023
Registration Number
4680241
Registration Date
Tuesday, February 3, 2015
Filing Date
Tuesday, April 2, 2013
Published for Opposition
Tuesday, November 18, 2014
Cancellation Date
Sunday, April 2, 2023
40 [ Custom manufacture of nano-particles; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices ]
9 [ Computer software for the sampling, collection, analysis and testing of nano-particles; computer software for the diagnosis of medical conditions; electronic devices, namely, computers, laboratory analyzers in the nature of residual gas analyzers, liquid analyzers, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence or quantity of target chemicals, biologics, contaminants and nano-particles, untrasound probes for testing nano-particles for non-medical purposes, scientific diagnostic apparatus in the nature of diagnostic apparatus for testing food, diagnostic apparatus for the detection of pathogens for laboratory or research use, spectroscopic devices in the nature of laboratory spectroscopes, microfluidic devices in the nature of electronic analyzers for the transport and analysis for fluid samples by using microfluidic and nanofluidic channels formed on or in a substrate, laboratory equipment in the nature of digital microfluidic instruments for nucleic acid sample preparation, laboratory equipment in the nature of digital microfluidic instruments for genomic analysis, equipment for microfluidic analysis, research laboaratory analyzers for measuring, testing and analyzing fluids, laboratory microarray devices for the sampling, collection, analysis and testing of nano-particles ]
5 [ Pharmaceuticals and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles ]
1 [ Active chemical ingredients for use in the manufacture of pharmaceuticals and medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; Active chemical ingredients for use in the manufacture of cosmetics, namely, nanoparticles for use as carriers for cosmetic preparations; nano-particle ingredients for use in pharmaceuticals, medicines and cosmetics, namely, active chemical ingredients in the nature of nanoparticles for use in the manufacture of pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders ]
10 [ Medical devices, namely, medical diagnostic kits consisting primarily of probes, buffers and reagents for use in nano-particle testing, medical sample preparation devices for medical diagnostic uses, spectroscopic devices in the nature of microscopes for surgical operations, endoscopic equipment, otoscopes, microfluidic devices in the nature of medical fluid injectors, medical devices for obtaining body fluid samples containing nano-particles and medical diagnostic instuments for analysis of body fluids, microarray devices in the nature of microarrays for surgical use, microarrays for medical diagnostic use, and microarrays for the sampling, collection, analysis and testing of nano-particles for medical purposes; probes for medical purposes ]
42 [ Scientific research services in the field of nano-particle technology; ] pharmaceutical development and drug development and discovery services; testing, efficiency, quality evaluation and technical advisory services in the field of design, development and scientific research of [ nano-particles, ] pharmaceuticals [ and nano-medicine; nano-particle testing, quality evaluation and scientific research laboratory services ]
MIDA TECH
The wording "MIDATECH" has no meaning in a foreign language.
Oct 30, 2023
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Oct 30, 2023
Death Of International Registration
Jan 3, 2023
Partial Invalidation Processed By The Ib
Dec 2, 2022
Partial Invalidation Of Reg Ext Protection Sent To Ib
Dec 1, 2022
Invalidation Processed
Nov 5, 2022
Partial Invalidation Of Reg Ext Protection Created
Mar 5, 2022
Notice Of Acceptance Of Sec. 71 - E-Mailed
Mar 5, 2022
Registered - Partial Sec 71 Accepted
Feb 16, 2022
Case Assigned To Post Registration Paralegal
Jul 26, 2021
Teas Section 71 Received
Sep 18, 2020
Change Of Name/Address Rec'd From Ib
Feb 3, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Sep 10, 2015
New Representative At Ib Received
Jun 20, 2015
Final Decision Transaction Processed By Ib
Jun 3, 2015
Final Disposition Notice Sent To Ib
Jun 3, 2015
Final Disposition Processed
May 3, 2015
Final Disposition Notice Created, To Be Sent To Ib
Feb 3, 2015
Registered-Principal Register
Nov 18, 2014
Official Gazette Publication Confirmation E-Mailed
Nov 18, 2014
Published For Opposition
Nov 14, 2014
Notification Processed By Ib
Oct 29, 2014
Notification Of Possible Opposition Sent To Ib
Oct 29, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 29, 2014
Notification Of Notice Of Publication E-Mailed
Oct 16, 2014
Law Office Publication Review Completed
Oct 14, 2014
Approved For Pub - Principal Register
Oct 14, 2014
Teas/Email Correspondence Entered
Oct 14, 2014
Correspondence Received In Law Office
Oct 14, 2014
Teas Request For Reconsideration Received
Apr 14, 2014
Notification Of Final Refusal Emailed
Apr 14, 2014
Final Refusal E-Mailed
Apr 14, 2014
Final Refusal Written
Mar 24, 2014
Teas/Email Correspondence Entered
Mar 24, 2014
Correspondence Received In Law Office
Mar 20, 2014
Assigned To Lie
Mar 5, 2014
Teas Response To Office Action Received
Sep 30, 2013
Refusal Processed By Ib
Sep 10, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Sep 10, 2013
Refusal Processed By Mpu
Sep 10, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Sep 10, 2013
Application Filing Receipt Mailed
Sep 9, 2013
Non-Final Action Written
Sep 6, 2013
Assigned To Examiner
Sep 6, 2013
New Application Office Supplied Data Entered
Sep 5, 2013
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
